The UK Medicines and Healthcare products Regulatory Agency has issued an updated notice alerting healthcare professionals against the dangers of off-label use of medical devices, unsanctioned user modification of devices and using non CE-marked products for clinical purposes1...
Scrip Regulatory Affairs
UK MHRA warns against off-label use, user modifications
05 January 2010
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA cites examples of its stricter medtech regulations vs EU
- Regulators, governments divided over action on PIP breast implants
- Australian Senate panel inquiry expresses shock at patient experiences with DePuy hip devices; calls for stricter regulations
- EU panel plans to report on safety of PIP implants by month end as criticism of system continues
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
